-
Je něco špatně v tomto záznamu ?
The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease
R Skaba, S Dvorakova, E Vaclavikova, P Vlcek, M Frantlova, B Bendlova
Jazyk angličtina Země Německo
Typ dokumentu práce podpořená grantem
Grantová podpora
NR7806
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
SpringerLink Journals
od 1997-02-01 do 2009-04-30
ProQuest Central
od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-02-01 do Před 1 rokem
Family Health Database (ProQuest)
od 1997-02-01 do Před 1 rokem
- MeSH
- dítě MeSH
- dospělí MeSH
- Hirschsprungova nemoc epidemiologie genetika MeSH
- kojenec MeSH
- komorbidita MeSH
- lidé středního věku MeSH
- lidé MeSH
- medulární karcinom epidemiologie chemicky indukované MeSH
- mladiství MeSH
- nádory štítné žlázy epidemiologie genetika MeSH
- předškolní dítě MeSH
- protoonkogenní proteiny c-ret genetika MeSH
- riziko MeSH
- zárodečné mutace MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
Hirschsprung's disease (HD) can be associated with the development of neuroendocrine tumours such as medullary thyroid carcinoma (MTC). The RET proto-oncogene is the major gene responsible for both HD and MTC. Mutations in exon 10 (codons 609, 611, 618, 620) were found in patients with co-occurrence of HD and MTC. The aim of the study was to screen the MTC risk in patients with HD. The prospective and retrospective genetic analyses comprised 56 HD patients (41 males, 15 females, aged 0-47). The prospective subgroup of patients consisted of 34 patients (25 boys, 9 girls) operated on between June 2003 and December 2005. The retrospective subgroup comprised 22 patients (16 boys, 6 girls) of 194 patients who were operated on between December 1979 and May 2003, non-systematically chosen preferably for total colonic aganglionosis (TCA). DNAs were isolated from blood and resected segments of aganglionic bowel. The HD patients and nine available family members (2 HD) were tested for RET mutations in exons 10, 11, 13, 14, 15 and 16. Direct double-stranded fluorescent sequencing revealed typical germline heterozygous MTC risk RET mutations in 3/56 (5.4%) female HD patients: Cys609Tyr, Cys620Arg (both exon 10) and Tyr791Phe (exon 13). Two of these patients had TCA and one patient had classical type of HD. One TCA patient developed clinical stage of MTC and underwent total thyroidectomy (TTE). The other two RET positive HD patients (aged 7 and 25 years) are screened for calcitonin level and they are without TTE till now. Two family members (mothers of TCA patients) with detected RET mutation underwent prophylactic TTE with MTC finding. Results showed the benefit of systematic RET mutation screening in HD patients in order to identify the risk of MTC in preclinical stage of the disease in patients with HD and their family members. We recommend to investigate not only exon 10 but also exon 13.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13027128
- 003
- CZ-PrNML
- 005
- 20130820154732.0
- 007
- ta
- 008
- 130819s2006 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00383-006-1785-6 $2 doi
- 035 __
- $a (PubMed)17021738
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Škába, Richard, $d 1949- $7 jn20000402842 $u Department of Pediatric Surgery of the 2nd Faculty of Medicine, Charles University and Hospital Prague - Motol, V Uvalu 84, 150 06 Prague, Czech Republic
- 245 14
- $a The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease / $c R Skaba, S Dvorakova, E Vaclavikova, P Vlcek, M Frantlova, B Bendlova
- 504 __
- $a Literatura
- 520 9_
- $a Hirschsprung's disease (HD) can be associated with the development of neuroendocrine tumours such as medullary thyroid carcinoma (MTC). The RET proto-oncogene is the major gene responsible for both HD and MTC. Mutations in exon 10 (codons 609, 611, 618, 620) were found in patients with co-occurrence of HD and MTC. The aim of the study was to screen the MTC risk in patients with HD. The prospective and retrospective genetic analyses comprised 56 HD patients (41 males, 15 females, aged 0-47). The prospective subgroup of patients consisted of 34 patients (25 boys, 9 girls) operated on between June 2003 and December 2005. The retrospective subgroup comprised 22 patients (16 boys, 6 girls) of 194 patients who were operated on between December 1979 and May 2003, non-systematically chosen preferably for total colonic aganglionosis (TCA). DNAs were isolated from blood and resected segments of aganglionic bowel. The HD patients and nine available family members (2 HD) were tested for RET mutations in exons 10, 11, 13, 14, 15 and 16. Direct double-stranded fluorescent sequencing revealed typical germline heterozygous MTC risk RET mutations in 3/56 (5.4%) female HD patients: Cys609Tyr, Cys620Arg (both exon 10) and Tyr791Phe (exon 13). Two of these patients had TCA and one patient had classical type of HD. One TCA patient developed clinical stage of MTC and underwent total thyroidectomy (TTE). The other two RET positive HD patients (aged 7 and 25 years) are screened for calcitonin level and they are without TTE till now. Two family members (mothers of TCA patients) with detected RET mutation underwent prophylactic TTE with MTC finding. Results showed the benefit of systematic RET mutation screening in HD patients in order to identify the risk of MTC in preclinical stage of the disease in patients with HD and their family members. We recommend to investigate not only exon 10 but also exon 13.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a mladiství $7 D000293
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a medulární karcinom $x epidemiologie $x chemicky indukované $7 D018276
- 650 02
- $a dítě $7 D002648
- 650 02
- $a předškolní dítě $7 D002675
- 650 02
- $a komorbidita $7 D015897
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a zárodečné mutace $7 D018095
- 650 02
- $a Hirschsprungova nemoc $x epidemiologie $x genetika $7 D006627
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kojenec $7 D007223
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a protoonkogenní proteiny c-ret $x genetika $7 D051096
- 650 02
- $a riziko $7 D012306
- 650 02
- $a nádory štítné žlázy $x epidemiologie $x genetika $7 D013964
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dvořáková, Šárka $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic $7 xx0080456
- 700 1_
- $a Václavíková, Eliška $7 xx0228492 $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vlček, Petr, $d 1961- $7 xx0003505 $u Department of Nuclear Medicine and Endocrinology of the 2nd Facultty of Medicine, Charles University Hospital Prague—Motol, Prague, Czech Republic
- 700 1_
- $a Frantlová, Miroslava $7 xx0137284 $u Department ol nd Molecular Medicine the 2nd Faculty of Medicine, Charles University l Hospital Prague—Motol, Prague, Czech Republic
- 700 1_
- $a Bendlová, Běla, $d 1962- $7 jo20000074069 $u Department of Molecular Endocrinology, Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $t Pediatric Surgery International $x 0179-0358 $g Roč. 22, č. 12 (2006), s. 991-995 $p Pediatr Surg Int $w MED00003742
- 773 0_
- $p Pediatr Surg Int $g 22(12):991-5, 2006 Dec $x 0179-0358
- 910 __
- $a ABA008 $b B 1134 $y 3 $z 0
- 990 __
- $a 20130819131205 $b ABA008
- 991 __
- $a 20130820155248 $b ABA008
- 999 __
- $a ok $b bmc $g 991010 $s 825553
- BAS __
- $a 3
- BMC __
- $x MED00003742 $i 0179-0358 $a 2006 $b 22 $c 12 $d 991-995 $m Pediatric surgery international $n Pediatr Surg Int
- GRA __
- $a NR7806 $p MZ0
- LZP __
- $a 2013-08/gvbo
